GNLX News - Candlesense

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

(NASDAQ:GNLX) WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick,...

Investor events

about 12 hours ago

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second qua...

Are there any forward‑looking statements or macro‑economic factors highlighted that could impact the company's long‑term growth trajectory? What is the market's reaction to the earnings release (e.g., pre‑market trading, analyst upgrades/downgrades), and what factors are driving that sentiment? Did the company address any changes in its capital structure, such as equity offerings, debt financing, or share repurchases, that could affect liquidity?

Earnings

26 days ago